Stockscreener 앱 받기
1.15
3.60%
0.04
시간 외 거래:
1.12
-0.03
-2.61%
전일 마감가:
$1.11
열려 있는:
$1.15
하루 거래량:
243.84K
Relative Volume:
0.69
시가총액:
$13.40M
수익:
$41.71M
순이익/손실:
$-10.54M
주가수익비율:
-0.9781
EPS:
-1.1757
순현금흐름:
$-13.36M
1주 성능:
+2.68%
1개월 성능:
+17.36%
6개월 성능:
+5.50%
1년 성능:
+64.29%
1일 변동 폭
$1.12
$1.185
1주일 범위
$1.04
$1.185
52주 변동 폭
$0.536
$1.19
Biofrontera Inc Stock (BFRI) Company Profile
명칭
Biofrontera Inc
전화
781-245-1325
주소
120 PRESIDENTIAL WAY,, WOBURN
Compare BFRI vs TAK, ZTS, TEVA, HLN, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BFRI
Biofrontera Inc
|
1.15 | 12.93M | 41.71M | -10.54M | -13.36M | -1.1757 |
TAK
Takeda Pharmaceutical Co Adr
|
16.55 | 52.32B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
112.54 | 47.38B | 9.47B | 2.67B | 2.28B | 6.0218 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.86 | 41.16B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.17 | 41.02B | 14.54B | 2.22B | 2.58B | 0.4871 |
UTHR
United Therapeutics Corp
|
572.20 | 24.67B | 3.18B | 1.33B | 1.04B | 27.90 |
Biofrontera Inc 주식(BFRI)의 최신 뉴스
Equity incentives and director votes at Biofrontera (NASDAQ: BFRI) 2026 meeting - Stock Titan
Biofrontera : Proxy of the Company (Proxy of the Company) - marketscreener.com
Biofrontera sees Q4 2025 net sales of about $17M to $17.5M - MSN
BFRI Biofrontera posts strong Q4 2025 EPS beat, shares dip 0.91% as investors weigh long-term growth risks.Crowd Sentiment Stocks - Cổng thông tin điện tử tỉnh Tây Ninh
Biofrontera AG Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Biofrontera : Annual report 2025 (Annual report 2025) - marketscreener.com
PTA-News: Biofrontera AG: BIOFRONTERA REPORTS RESULTS FOR THE FINANCIAL YEAR 2025 - TradingView
Biofrontera (BFRI) Stock Iron Condor (Investor Interest) 2026-04-16Viral Trade Signals - Xã Thanh Hà
Biofrontera Inc. (BFRI) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - Eastern Progress
Is Biofrontera (BFRI) Stock Cheap at Current Price | Price at $1.01, Down 1.46%Fundamentals - Newser
Biofrontera signals enhanced operating leverage as U.S. independence and new patent reshape outlook - MSN
Bull Bear: Is Biofrontera Inc Equity Warrant exposed to currency risksDollar Strength & Weekly Top Stock Performers List - baoquankhu1.vn
Biofrontera Inc. to Report First Quarter FY 2025 Financial Results on May 15, 2025 - marketscreener.com
BFRI Technical Analysis & Stock Price Forecast - Intellectia AI
BFRIW Stock Analysis: Biofrontera Inc. Warrants at 0.06 posts 3.07 percent daily gain - UBND thành phố Hải Phòng
Portfolio Shifts: Is now the right time to enter Biofrontera Inc Equity WarrantGap Down & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Biofrontera (BFRI) Projected to Post Earnings on Friday - Defense World
Risk Report: How does Biofrontera Inc Equity Warrant compare to its peersWeekly Market Outlook & Real-Time Sentiment Analysis - baoquankhu1.vn
Moving Averages: Can Biofrontera Inc stock outperform in a bear marketTrade Analysis Summary & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Biofrontera Inc PE Ratio (TTM) & PE Ratio (TTM) ChartsBFRI - GuruFocus
Biofrontera reports rise in Q4 revenue, turns profitable - MSN
If You Invested $1,000 in Biofrontera Inc (BFRI) - Stock Titan
Layoff Watch: Is Biofrontera Inc forming a breakout pattern2026 PostEarnings & High Conviction Buy Zone Alerts - baoquankhu1.vn
Biofrontera Inc (BFRI) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... By GuruFocus - ca.investing.com
BFRI PE Ratio & Valuation, Is BFRI Overvalued - Intellectia AI
Biofrontera’s New Royalty Agreement Drives Gross Margins Above 82%, Opening Up New Profit Opportunities - Bitget
Biofrontera Inc. (NASDAQ:BFRI) Q4 2025 Earnings Call Transcript - Insider Monkey
Biofrontera 2025 Company Overview: Ameluz Photodynamic Therapy, Product Pipeline, and U.S. Market Strategy - Minichart
Biofrontera Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Biofrontera Earnings Call: Profits Rise, Risks Remain - tipranks.com
BFRIW SEC FilingsBiofrontera 10-K, 10-Q, 8-K Forms - Stock Titan
BIOFRONTERA ($BFRI) Releases Q4 2025 Earnings - quiverquant.com
[10-K] Biofrontera Inc. Files Annu... - Stock Titan
Biofrontera outlines 80%-85% gross margin target for 2026 following strategic asset acquisition - MSN
Biofrontera Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2025 - marketscreener.com
Earnings call transcript: Biofrontera Inc. Q4 2025 sees record revenue growth - Investing.com Australia
Biofrontera 2025 Financial Results: Record Annual & Quarterly RevenueNews and Statistics - IndexBox
Biofrontera Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Biofrontera (BFRI) Q4 2025 Financial Results Transcript - Bitget
Biofrontera (BFRI) Q4 2025 Earnings Transcript - The Globe and Mail
BFRI: Record revenue, improved margins, and clinical progress set up strong 2026 growth - TradingView
Earnings call transcript: Biofrontera Inc. Q4 2025 sees record revenue growth By Investing.com - Investing.com South Africa
Biofrontera reports Q4 revenue $17.1M vs. $12.6M last year - tipranks.com
Biofrontera reports record Q4 revenue $17.1M, Q4 gross margin 82.4% and Q4 net income $5.6M - TradingView
Biofrontera Inc. Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update - The Manila Times
Record Q4 for Biofrontera (NASDAQ: BFRI) with 36% revenue growth - Stock Titan
Price Action: Does Biofrontera Inc have a sustainable dividend2026 Pullbacks & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Nasdaq Moves: Does Biofrontera Inc Equity Warrant have pricing power2026 Snapshot & Real-Time Chart Breakout Alerts - baoquankhu1.vn
Biofrontera Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Biofrontera Inc expected to post earnings of 20 cents a shareEarnings Preview - TradingView
BFRIWBiofrontera Latest Stock News & Market Updates - Stock Titan
Biofrontera Inc (BFRI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.67%
2.13%
자본화:
|
볼륨(24시간):